Primary and secondary prevention of cardiovascular diseases
Primary and secondary prevention of cardiovascular diseases
All ingredients, such as garlic and cinnamon bark in Cardio Balance, have proved to reduce blood pressure. The combination of these ingredients in the right quantity has shown massive improvement in managing blood pressure.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Primary and secondary prevention of cardiovascular diseasesCardiovascular diseases (CVD) are one of the leading causes of death worldwide. Its prevention is therefore a key challenge for the health system. A distinction between primary and secondary prevention, which include different target groups and strategies.Primary PreventionPrimary prevention aims cardiovascular disease is to prevent persons who have no clinical symptoms. It focuses on the modification of risk factors known to be associated with an increased risk of the disease are associated. Among the most important risk factors:arterial hypertension;Hyperlipidemia;Diabetes mellitus;Tobacco consumption;physical inactivity;unhealthy diet;Overweight and obesity;chronic Stress.Measures of primary prevention include:Health education and training: raising people's awareness of healthy lifestyles, prevention campaigns for Smoking abstinence and reduction of salt consumption.Behavior modification: the promotion of regular physical activity (at least 150 minutes of moderate activity per week), recommendations for a balanced diet (e.g., the DASH diet or Mediterranean diet).Drug interventions in high-risk patients: if necessary, administration of Lipid-lowering agents (statins) or antihypertensives in the case of individually balanced Benefit‑risk assessment.Secondary PreventionSecondary prevention concerns patients who have already had a cardiovascular disease (e.g., myocardial infarction, stroke, peripheral arterial disease). Your goal is the prevention of relapses and complications as well as improving the quality of life and life expectancy.Essential elements of secondary prevention are:Drug Therapy:Platelet aggregation inhibitors (e.g., acetylsalicylic acid);Beta-blockers after myocardial infarction;ACE inhibitors or AT1‑receptor blockers in heart failure or after myocardial infarction;Statins for lipid-lowering;Antihypertensive drugs to control blood pressure.Life style modifications: ongoing support in the case of Smoking, weight reduction, physical activity and diet.Cardiac Rehabilitation: a structured programs, the physical training sessions, psycho include social support and Patient education.Regular follow-up blood pressure, cholesterol and blood sugar monitoring and, if necessary, exercise ECG or imaging procedures.ConclusionEffective prevention of cardiovascular diseases requires an integrated approach that combines primary and secondary measures. While primary prevention is aimed at risk prevention, and focuses the secondary prevention on the optimization of the therapy and the reduction of recurrence risk. A close cooperation between family doctors, cardiologists, physical therapists, and nutritionists, as well as the active participation of the patient to the success of these strategies is crucial.Would you like me to make a certain section in more detail, or other aspects of complementary?
Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso. Primary and secondary prevention of cardiovascular diseases. People have long used Hawthorne berries for treating high bp, heart issues, and cholesterol levels. A number of Clinical research conclude that it improves cardiovascular function, shortness of breath, and fatigue. In another study, 1200 mg hawthorn extract or placebo was taken by hypertension patients for 16 weeks. Those who were taking hawthorn extract had a significant decrease in blood pressure than the other group taking a placebo.
Describe the main causes of cardiovascular diseases short
Rehabilitation after cardiovascular diseases
Cardiovascular diseases and pregnancy clinical recommendations
What is the difference between the Phase of the degree of hypertension
emed.co.in/userfiles/medicines-for-high-blood-pressure-for-people-with-epilepsy.xml
www.shetravels.eu/userfiles/the-main-causes-of-cardiovascular-diseases-short.xml
Constant high levels of stress can disturb the blood flow and blood pressure and can damage vessels, and you may experience dizziness, extreme fatigue, or body aches with no wish to get out of bed. This stress-induced fatigue can make your blood pressure high and needs to be monitored. Ang pagkontrol sa presyon ay isang napakahalagang gawain, dahil ang pag-inom ng mga tableta na nakakatulong sa pagpapanatili ng normal na mga indikador ay maaaring magbigay ng araw-araw na komportableng buhay, upang maiwasan ang panganib ng hypertensive crisis, atake sa puso, at stroke. Ang mga gamot para sa kontrol ng presyon ay medyo malawakang makukuha sa mga botika, pero tanging ang doktor lang ang makakapili ng tamang gamot na angkop sa therapy. Lahat ng grupo ng gamot para pababain ang presyon ay may iba't ibang mekanismo ng epekto, side effects, at may kaunting posibilidad ng pagkadepende. Ang tamang pagpili ng gamot ay nagbibigay ng mabilis at tuloy-tuloy na resulta, at ang eksperimento sa sarili sa pag-inom ng gamot ay may mataas na posibilidad ng biglaang karamdaman, sakit sa puso at daluyan ng dugo, at sa matinding kaso, maaaring magdulot ng kamatayan.
Of course! Here is a scientific Text to English on the subject of A cure for Diabetes and hypertension:A possible cure for Diabetes mellitus and arterial hypertension: New perspectives in the combined therapySummaryType 2 Diabetes mellitus and arterial hypertension are associated often comorbid and increase in common cardiovascular risk. The search for an integrated therapeutic approach that addresses both disorders at the same time, is becoming increasingly important. In this paper, the latest research results will be presented to a promising drug candidates that could influence the regulation of blood sugar as well as blood pressure.IntroductionThe combination of Diabetes mellitus type 2 (DM2) and arterial hypertension (AH) provides one of the most important health challenges of the 21st century. This century. Epidemiological studies show that up to 80% of patients with DM2 suffering from a AH. This co-morbidity leads to a significant increase in the risk for heart attack, stroke, and kidney disease.Current therapy concepts, the separate treatment of the two diseases: the Case of DM2 Metformin, GLP‑1 analogues or SGLT2 inhibitors are used; in the case of AH, ACE‑inhibitors, AT1 be prescribed receptor blockers, calcium channel blockers, or diuretics. A combined therapy, however, entails the risk of interactions and increases the medication burden for the patient.New Active Substance: X‑743In recent preclinical and early clinical studies, the active ingredient X‑743 has shown (a new class of dual SGLT/NHE inhibitors) with promising properties. The mechanism of action is based on:inhibition of renal Glucose Transporter, SGLT2, which leads to an increased Glycosuria, and thus to a drop in blood sugar levels;a simultaneous inhibition of the Na⁺/H⁺‑exchanger (NHE1) in smooth muscle cells of the blood vessels, which has vasodilatory effects and a blood pressure lowering effect.First clinical resultsA Phase II study with 150 patients (mean age: 58±7 years, HbA1c of 8.2±1.1%, and blood pressure: 152/94±12/8 mmHg) showed, after twelve weeks the following improvements:The reduction of HbA1c by 1.3%;Reduction in systolic blood pressure by 14 mmHg;Decrease in body weight by an average of 3.5 kg;no significant increase in hypoglycemic events.The side-effect profiles were comparable with those of conventional SGLT2 inhibitors (moderate dehydration in 5% of participants, no severe infections).Discussion and OutlookThe active ingredient X‑743 could initiate a paradigm shift in the treatment of DM2, and AH. Due to its dual effect, he could reduce the medication burden, improve Compliance and long-term cardiovascular risk lower. Further large-scale randomized trials (Phase III) are required to confirm the long-term safety and effectiveness.ConclusionX‑743 is a promising candidate for combined therapy of type 2 Diabetes mellitus and arterial hypertension. The results of the early studies give rise to cautious optimism, and underline the need for further research in this area.If you want, I can make certain sections in more detail or further aspects!
